文献速递中毒与环境急症儿科与产科急症

急诊科儿童大麻中毒的资源利用情况

Resource utilization among children presenting with cannabis poisonings in the emergency department.
PubMed 文献 · Am J Emerg Med · 2023-09-09
一句话结论儿童探索性大麻中毒急诊就诊量每年增加68.7%,但辅助检查比例未随时间变化;作者建议对急性精神状态改变的患儿早期考虑该诊断。

该研究为回顾性横断面研究,基于儿科健康信息系统数据库,纳入2016年1月至2021年12月年龄0-10岁儿童的所有大麻中毒病例,共2001次暴露、1999名儿童。大麻暴露每10万次急诊就诊每年增加68.7%(95%CI 50.3-89.3),每次就诊诊断性检查中位数为4项(IQR 2.0-6.0),64.5%接受血液检查、28.8%接受CT扫描、2.4%接受腰椎穿刺。黑色人种较白色人种更可能接受辅助检查(OR 1.52,95%CI 1.23-1.89),<2岁较2-6岁更可能接受辅助检查(OR 1.55,95%CI 1.19-2.02),辅助检查的 odds 无显著年度变化(OR 1.04,95%CI 0.97-1.12)。作者认为急诊提供者应在评估急性精神状态改变的患儿时早期考虑该诊断,早期使用尿液药物筛查可能减少辅助检查和侵入性操作,但即使尿液药物筛查阳性也不能排除其他病变,不应替代深思熟虑的评估。

要点

  • 0-10岁儿童大麻暴露每10万次急诊就诊每年增加68.7%(95%CI 50.3-89.3)。
  • 每次就诊诊断性检查中位数为4项(IQR 2.0-6.0),64.5%接受血液检查、28.8%接受CT扫描、2.4%接受腰椎穿刺。
  • 黑色人种较白色人种更可能接受辅助检查(OR 1.52,95%CI 1.23-1.89)。
  • <2岁较2-6岁更可能接受辅助检查(OR 1.55,95%CI 1.19-2.02)。
  • 辅助检查的 odds 无显著年度变化(OR 1.04,95%CI 0.97-1.12)。

适用人群与场景

  • 0-10岁儿童,2016年1月至2021年12月期间因大麻中毒在急诊就诊的病例。

研究设计与关键结果

  • 研究类型:回顾性横断面研究,基于儿科健康信息系统数据库,纳入2001次大麻暴露、1999名儿童。
  • 主要终点:大麻暴露每10万次急诊就诊每年增加68.7%(95%CI 50.3-89.3)。
  • 每次就诊诊断性检查中位数为4项(IQR 2.0-6.0)。
  • 64.5%的就诊接受血液检查,28.8%接受CT扫描,2.4%接受腰椎穿刺。
  • 黑色人种较白色人种更可能接受辅助检查(OR 1.52,95%CI 1.23-1.89)。
  • <2岁较2-6岁更可能接受辅助检查(OR 1.55,95%CI 1.19-2.02)。
  • 辅助检查的 odds 无显著年度变化(OR 1.04,95%CI 0.97-1.12)。

证据类型、等级与局限

  • 证据类型:回顾性横断面研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,鉴于儿童大麻中毒发生率增加,急诊提供者应在评估急性精神状态改变的患儿时早期考虑该诊断。
  • 作者认为,早期使用尿液药物筛查可能减少辅助检查和侵入性操作,但即使尿液药物筛查阳性也不能排除其他病变,不应替代深思熟虑的评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Exploratory pediatric cannabis poisonings are increasing. The aim of this study is to provide a national assessment of the frequency and trends of diagnostic testing and procedures in the evaluation of pediatric exploratory cannabis poisonings.

METHODS: This is a retrospective cross-sectional study of the Pediatric Health Information Systems database involving all cases of cannabis poisoning for children age 0-10 years between 1/2016 and 12/2021. Cannabis poisoning trends were assessed using a negative binomial regression model. A new variable named "ancillary testing" was created to isolate testing that would not confirm the diagnosis of cannabis poisoning or be used to exclude co-ingestion of acetaminophen or aspirin. Ancillary testing was assessed with regression analyses, with ancillary testing as the outcomes and year as the predictor, to assess trends over time.

RESULTS: A total of 2001 cannabis exposures among 1999 children were included. Cannabis exposures per 100,000 ED visits increased 68.7% (95% CI, 50.3, 89.3) annually. There was a median of 4 (IQR 2.0, 6.0) diagnostic tests performed per encounter. 64.5% of encounters received blood tests, 28.8% received a CT scan, and 2.4% received a lumbar puncture. Compared to White individuals, Black individuals were more likely to receive ancillary testing (OR 1.52 [95% CI, 1.23, 1.89]). Compared to those 2-6 years, those <2 years were more likely to receive ancillary testing (OR 1.55 [95% CI, 1.19, 2.02). We found no significant annual change in the odds of receiving ancillary testing (OR 1.04 [95% CI, 0.97, 1.12]).

CONCLUSIONS: We found no change in the proportion of encounters associated with ancillary testing, despite increases in exploratory cannabis poisonings over the study period. Given the increasing rate of pediatric cannabis poisonings, emergency providers should consider this diagnosis early in the evaluation of a pediatric patient with acute change in mental status. While earlier use of urine drug screening may reduce ancillary testing and invasive procedures, even a positive urine drug screen does not rule out alternative pathologies and should not replace a thoughtful evaluation.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Toce MS, Dorney K, D'Ambrosi G, et al. Resource utilization among children presenting with cannabis poisonings in the emergency department. Am J Emerg Med. 2023. PMID: 37696075. doi:10.1016/j.ajem.2023.09.002

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。